|
|
Other links at Articles > Dermatology |
| 1. |
The PUVA Follow-up Study
|
|
|
This study has generated a wealth of information about psoriasis treatment, but the results are not encouraging.
|
| 3. |
Sorafenib Plus Dacarbazine Shows Promise in Advanced Melanoma
|
|
|
In a phase II study of chemotherapy-naive patients with stage III (unresectable) or stage IV melanoma, the addition of the Raf kinase inhibitor sorafenib to dacarbazine yielded an "encouraging" improvement in progression-free survival, the primary endpoint, and was well tolerated, researchers report. Reuters Health Information
|
|
|
